nitisinone has been researched along with Chronic Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altay, S; Aydin, A; Cansever, S; Erkan, T; Kiykim, E; Soyucen, E; Zeybek, AC; Zubarioglu, T | 1 |
| Al-Dhalimy, M; Finegold, M; Grompe, M; Groopman, J; Iordanov, MS; Ou, CN; Ryabinina, O; van Den Berg, IE; Vogel, A | 1 |
| Holme, E; Lambruschini, N; Lindstedt, S; Mas, A; Ros, J; Vilaseca, MA | 1 |
3 other study(ies) available for nitisinone and Chronic Disease
| Article | Year |
|---|---|
Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience.
Topics: Acute Disease; Child; Child, Preschool; Chronic Disease; Cyclohexanones; Diet Therapy; Early Diagnosis; Enzyme Inhibitors; Female; Hepatomegaly; Humans; Infant; Infant, Newborn; Kidney Diseases; Liver Transplantation; Living Donors; Male; Nitrobenzoates; Prognosis; Retrospective Studies; Splenomegaly; Turkey; Tyrosinemias | 2015 |
Chronic liver disease in murine hereditary tyrosinemia type 1 induces resistance to cell death.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Apoptosis; Cell Survival; Central Nervous System Depressants; Chronic Disease; Cyclohexanones; Enzyme Inhibitors; Ethanol; Fas Ligand Protein; fas Receptor; Glutathione; Homogentisic Acid; HSP70 Heat-Shock Proteins; Hydrolases; Liver Failure, Acute; Membrane Glycoproteins; Mice; Mice, Mutant Strains; Necrosis; NF-kappa B; Nitrobenzoates; Oxidative Stress; Proto-Oncogene Proteins c-jun; Tyrosinemias; Up-Regulation | 2004 |
NTBC as palliative treatment in chronic tyrosinaemia type I.
Topics: 4-Hydroxyphenylpyruvate Dioxygenase; Adolescent; Amino Acid Metabolism, Inborn Errors; Chronic Disease; Cyclohexanones; Fatal Outcome; Humans; Male; Nitrobenzoates; Tyrosine | 1999 |